These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31281861)

  • 1. Optimal Duration of Follow-up for Assessing Antimalarial Efficacy in Pregnancy: A Retrospective Analysis of a Cohort Followed Up Until Delivery on the Thailand-Myanmar Border.
    Saito M; Mansoor R; Wiladphaingern J; Paw MK; Pimanpanarak M; Proux S; Guérin PJ; White NJ; Nosten F; McGready R
    Open Forum Infect Dis; 2019 Jul; 6(7):ofz264. PubMed ID: 31281861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border.
    Saito M; Carrara VI; Gilder ME; Min AM; Tun NW; Pimanpanarak M; Viladpai-Nguen J; Paw MK; Haohankhunnatham W; Konghahong K; Phyo AP; Chu C; Turner C; Lee SJ; Duanguppama J; Imwong M; Bancone G; Proux S; Singhasivanon P; White NJ; Nosten F; McGready R
    BMC Med; 2021 Jun; 19(1):132. PubMed ID: 34107963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intervals to Plasmodium falciparum recurrence after anti-malarial treatment in pregnancy: a longitudinal prospective cohort.
    Laochan N; Zaloumis SG; Imwong M; Lek-Uthai U; Brockman A; Sriprawat K; Wiladphaingern J; White NJ; Nosten F; McGready R
    Malar J; 2015 May; 14():221. PubMed ID: 26017553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy.
    McGready R; Tan SO; Ashley EA; Pimanpanarak M; Viladpai-Nguen J; Phaiphun L; Wüstefeld K; Barends M; Laochan N; Keereecharoen L; Lindegardh N; Singhasivanon P; White NJ; Nosten F
    PLoS Med; 2008 Dec; 5(12):e253. PubMed ID: 19265453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria.
    Zani B; Gathu M; Donegan S; Olliaro PL; Sinclair D
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD010927. PubMed ID: 24443033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized Controlled Trial of the Electrocardiographic Effects of Four Antimalarials for Pregnant Women with Uncomplicated Malaria on the Thailand-Myanmar Border.
    Saito M; Yotyingaphiram W; Cargill Z; Gilder ME; Min AM; Phyo AP; San TD; Poe H; Chu C; White NJ; Nosten F; McGready R
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33495217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.
    Davlantes E; Dimbu PR; Ferreira CM; Florinda Joao M; Pode D; Félix J; Sanhangala E; Andrade BN; Dos Santos Souza S; Talundzic E; Udhayakumar V; Owens C; Mbounga E; Wiesner L; Halsey ES; Martins JF; Fortes F; Plucinski MM
    Malar J; 2018 Apr; 17(1):144. PubMed ID: 29615039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.
    Smithuis F; Kyaw MK; Phe O; Win T; Aung PP; Oo AP; Naing AL; Nyo MY; Myint NZ; Imwong M; Ashley E; Lee SJ; White NJ
    Lancet Infect Dis; 2010 Oct; 10(10):673-81. PubMed ID: 20832366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.
    Blanshard A; Hine P
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD004529. PubMed ID: 33459345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.
    Yavo W; Faye B; Kuete T; Djohan V; Oga SA; Kassi RR; Diatta M; Ama MV; Tine R; Ndiaye JL; Evi JB; Same-Ekobo A; Faye O; Koné M
    Malar J; 2011 Jul; 10():198. PubMed ID: 21774826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
    Bustos MD; Wongsrichanalai C; Delacollette C; Burkholder B
    Southeast Asian J Trop Med Public Health; 2013; 44 Suppl 1():201-30; discussion 306-7. PubMed ID: 24159833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda.
    Ebong C; Sserwanga A; Namuganga JF; Kapisi J; Mpimbaza A; Gonahasa S; Asua V; Gudoi S; Kigozi R; Tibenderana J; Bwanika JB; Bosco A; Rubahika D; Kyabayinze D; Opigo J; Rutazana D; Sebikaari G; Belay K; Niang M; Halsey ES; Moriarty LF; Lucchi NW; Souza SSS; Nsobya SL; Kamya MR; Yeka A
    Malar J; 2021 Dec; 20(1):484. PubMed ID: 34952573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UK malaria treatment guidelines 2016.
    Lalloo DG; Shingadia D; Bell DJ; Beeching NJ; Whitty CJM; Chiodini PL;
    J Infect; 2016 Jun; 72(6):635-649. PubMed ID: 26880088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border.
    Na-Bangchang K; Ruengweerayut R; Mahamad P; Ruengweerayut K; Chaijaroenkul W
    Malar J; 2010 Oct; 9():273. PubMed ID: 20929590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine.
    Byakika-Kibwika P; Ssenyonga R; Lamorde M; Blessborn D; Tarning J
    BMC Infect Dis; 2019 Dec; 19(1):1025. PubMed ID: 31795967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azithromycin for treating uncomplicated malaria.
    van Eijk AM; Terlouw DJ
    Cochrane Database Syst Rev; 2011 Feb; 2011(2):CD006688. PubMed ID: 21328286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artemisinin-based combination therapy for treating uncomplicated malaria.
    Sinclair D; Zani B; Donegan S; Olliaro P; Garner P
    Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007483. PubMed ID: 19588433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
    Ashley EA; Krudsood S; Phaiphun L; Srivilairit S; McGready R; Leowattana W; Hutagalung R; Wilairatana P; Brockman A; Looareesuwan S; Nosten F; White NJ
    J Infect Dis; 2004 Nov; 190(10):1773-82. PubMed ID: 15499533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.